Research News and Research

RSS

New study sheds light on syndrome linked to aggressive pediatric cancer

A new study involving researchers at The University of Nottingham has revealed how children with an aggressive cancer predisposition syndrome experience a never before seen flood of mutations in their disease in just six months.

4 Feb 2015

Asthmatic patients suffering from xerostomia have a poorer level of control disease

Scientists at the University of Granada and the High Resolution Hospital in Loja (Granada) prove that asthmatic patients who suffer from xerostomia (dry mouth syndrome) have a poorer level of control disease. Whether an asthmatic patient also suffers from severe xerostomia can be of great use for the pneumologist when it comes to establishing that particular patient's level of control disease.

4 Feb 2015

Preliminary research supports alternative drug for treating neonatal abstinence syndrome

In the past decade, the number of Kentucky babies starting life with a drug dependency, or neonatal abstinence syndrome (NAS), has skyrocketed from 1.3 per 1,000 births to 19 per 1,000 births.

4 Feb 2015

New drug gets FDA approval for treatment of women with advanced breast cancer

The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.

4 Feb 2015

Merck announces US availability of BELSOMRA (suvorexant) for treatment of insomnia

Merck, known as MSD outside the United States and Canada, today announced that BELSOMRA (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia in adults who have difficulty falling asleep and/or staying asleep.

4 Feb 2015

COMBACTE-MAGNET project launched to study new treatment options for infections caused by MDR-GNB

Today 33 European academic partners and 5 pharmaceutical companies are launching a new project, COMBACTE-MAGNET, under the IMI antimicrobial resistance research programme New Drugs 4 Bad Bugs (ND4BB).

4 Feb 2015

OGT study explores successful adoption of CytoSure ISCA array at Sheffield Children's NHS Foundation Trust

Oxford Gene Technology, The Molecular Genetics Company, explores how Sheffield Children's NHS Foundation Trust has seamlessly transferred to its CytoSure ISCA 8x60k platform, in a new case study entitled Evaluating and switching to CytoSure microarrays. As the result of a highly stringent National Health Service tender for the supply of oligo-based cytogenetics research arrays, CytoSure was selected based on the quality of data and analysis software.

From Oxford Gene Technology 4 Feb 2015

Recession of mid-2000s continues to impact America's children

The bipartisan children's advocacy organization First Focus and PolicyLab at The Children's Hospital of Philadelphia released a new analysis today showing that, five years after its technical end, the recession of the mid-2000s continues to impact America's children.

4 Feb 2015

HIV science and treatment knowledge can end AIDS epidemic in the US

The scientific evidence is clear. As a result of extraordinary advances in biomedical research, we now have the tools we need to end the HIV epidemic in the United States. Or do we?

4 Feb 2015

Induced labor is not associated with Autism spectrum disorder, shows study

In a study to be presented on Feb. 5 in an oral pleanary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will report that induced or augmented labor are not associated with increased odds of Autism spectrum disorder.

4 Feb 2015

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

Amgen today announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.

4 Feb 2015

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

BioMed Realty Trust, Inc. today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Seattle, Washington for approximately $90 million.

4 Feb 2015

Study: Simple strategies can lead to significant improvements in one-year-olds at risk for ASD

A new study by University of North Carolina at Chapel Hill researchers finds that a collection of simple strategies used by parents can lead to significant improvements in one-year-olds at risk for autism spectrum disorder (ASD).

4 Feb 2015

Two genetic mutations can interact to reduce risk for heart attack

Researchers have determined that two mutations on a single gene can interact in a way that lowers the carrier's risk for a heart attack.

4 Feb 2015

Study opens door for development of tools to modulate CoQ10 synthesis in human cells

A study which counts with the participation of University of Granada scientists has provided new data on the Q10 coenzyme (CoQ10), a molecule which is synthesized within the cells of the organism itself and which has essential functions for cellular metabolism.

4 Feb 2015

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Congressman Chaka Fattah (D-PA), architect of the Fattah Neuroscience Initiative, met last week with Amarantus, a biotechnology company on their recent efforts to develop treatment and diagnostics for degenerative brain diseases, including Alzheimer's.

4 Feb 2015

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals.

4 Feb 2015

One in four nonsmokers still exposed to secondhand smoke, shows CDC report

Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers -- 58 million people -- are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.

4 Feb 2015

Scientists find eight different types of schizophrenia

Scientists from the universities of Granada (Spain) and Washington in St Louis (US) have found that there is not a single type of schizophrenia, but that it consists of a group made up of eight genetically different types of diseases, each of which presents its own set of symptoms.

4 Feb 2015

Study may offer insight into pathology of autism, Alzheimer's disease

For parents of children struggling with autism, the dearth of information is heartbreaking. Medical professionals are hard put to answer the primary questions: Who is autistic? What causes autism? What treatments are available? The situation is similar for Alzheimer's patients and relatives, who are helpless before the aggressive disease devouring a sufferer's identity.

4 Feb 2015

Research News and Research

New study sheds light on syndrome linked to aggressive pediatric cancer

Asthmatic patients suffering from xerostomia have a poorer level of control disease

Preliminary research supports alternative drug for treating neonatal abstinence syndrome

New drug gets FDA approval for treatment of women with advanced breast cancer

Merck announces US availability of BELSOMRA (suvorexant) for treatment of insomnia

COMBACTE-MAGNET project launched to study new treatment options for infections caused by MDR-GNB

OGT study explores successful adoption of CytoSure ISCA array at Sheffield Children's NHS Foundation Trust

Recession of mid-2000s continues to impact America's children

HIV science and treatment knowledge can end AIDS epidemic in the US

Induced labor is not associated with Autism spectrum disorder, shows study

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

Study: Simple strategies can lead to significant improvements in one-year-olds at risk for ASD

Two genetic mutations can interact to reduce risk for heart attack

Study opens door for development of tools to modulate CoQ10 synthesis in human cells

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

One in four nonsmokers still exposed to secondhand smoke, shows CDC report

Scientists find eight different types of schizophrenia

Study may offer insight into pathology of autism, Alzheimer's disease

Industry Focus eBook - Life Science Microscopy (3rd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy